If you need more lookups,
subscriptions start at $34 USD/month.
Inma Rioja Location
Cambridge, GB
Inma Rioja Work
Senior Vice President of Biology @ (April 2022 - Present)
SVP, Head of Therapeutics (Research and Innovation) @ (September 2024 - Present)
Head of Immuno-Epigenetics (Adaptive Immunity Research Unit) @ (September 2019 - April 2022)
Senior Director (Biology) and Portfolio Research Lead at Epigenetics DPU (Oncology TA) @ (June 2018 - September 2019)
Head of C3 DPU. Immuno-Inflammation TA. @ (July 2017 - June 2018)
Director, Head of Immuno-Pharmacology and Early Development Leader (EDL). Epigenetics DPU, iiTAU @ (November 2014 - July 2017)
Manager, Head Immuno-Pharmacology Team and Project Leader. Epigenetics DPU, Immuno-Inflammation TAU @ (February 2012 - October 2014)
Investigator, Project leader at Epi-Enzyme Research, Immuno-Inflammation Therapy Area (ii TAU) @ (May 2009 - February 2012)
Principal Scientist at Epi-Enzyme Research (DPU2), Immuno-Inflammation CEDD. @ (February 2009 - May 2009)
Principal Scientist. Immuno-Inflammation Experimental Medicine group. Respiratory CEDD @ (November 2006 - February 2009)
Senior Scientist. Rheumatoid Arthritis Biology Department. Respiratory and Inflammation CEDD @ (February 2006 - November 2006)
Postdoctoral Research Scientist. INSERM (ERM0324). Cellular and Molecular Biology Department. @ (April 2004 - August 2005)
Research Scientist (EU Postdoc). GlaxoSmithKline. RA Disease Biology Department. @ (March 2002 - March 2004)
Inma Rioja Education
Universitat de València
PhD (Pharmacology)
1998-2002
University of Valencia
Degree in Pharmacy (Pharmacology)
1992-1997
Inma Rioja Skills
Drug Discovery
Pharmacology
In Vitro
Biomarkers
In Vivo
Clinical Development
Drug Development
Immunology
Pharmacokinetics
Lifesciences
Cell Biology
Biochemistry
Molecular Biology
Pharmaceutical Industry
Cell
Translational Medicine
High Throughput Screening
Life Sciences
Assay Development
Inflammation
Research and Development R&d
Biomarker Discovery
Research and Development
Inma Rioja Summary
Inma Rioja, based in Cambridge, GB, is currently a Senior Vice President of Biology at Bicycle Therapeutics. Inma Rioja brings experience from previous roles at Bicycle Therapeutics and GSK. Inma Rioja holds a 1998 - 2002 PhD in Pharmacology @ Universitat de València. With a robust skill set that includes Drug Discovery, Pharmacology, In Vitro, Biomarkers, In Vivo and more. Inma Rioja has 1 emails on RocketReach.
Looking for a different Inma Rioja?
Find contact details for 700 million professionals.